Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018 (2018), Article ID 2450712, 12 pages
https://doi.org/10.1155/2018/2450712
Research Article

Effects of Angelica gigas Nakai as an Anti-Inflammatory Agent in In Vitro and In Vivo Atopic Dermatitis Models

1Wellbeing Tainment Co., Ltd, Gimhae 50969, Republic of Korea
2Department of Herbal Medicinal Pharmacology, College of Herbal Bio-Industry, Daegu Haany University, Kyungsan 38610, Republic of Korea
3Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunhyang University, Asan 31538, Republic of Korea

Correspondence should be addressed to Deok-Seon Ryu; rk.ca.hcs@2290edlih

Received 2 November 2017; Revised 29 December 2017; Accepted 28 January 2018; Published 11 March 2018

Academic Editor: Junji Xu

Copyright © 2018 Seon Ok et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Handout on health: Atopic dermatitis (A type of eczema), National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2013.
  2. E. Proksch, D. Dähnhardt, S. Dähnhardt-Pfeiffer, and R. Fölster-Holst, “Epidermal barrier disorders in dermatoses,” Hautarzt, vol. 67, no. 11, pp. 907–921, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Sullivan and N. B. Silverberg, “Current and emerging concepts in atopic dermatitis pathogenesis,” Clinics in Dermatology, vol. 35, no. 4, pp. 349–353, 2017. View at Publisher · View at Google Scholar
  4. N. B. Silverberg and J. I. Silverberg, “Inside out or outside in. does atopic dermatitis disrupt barrier function or does disruption of barrier function trigger atopic dermatitis?” Cutis, vol. 96, no. 6, pp. 359–361, 2015. View at Google Scholar
  5. P. Andersson and R. Brattsand, “Protective effects of the glucocorticoid, budesonide, on lung anaphylaxis in actively sensitized guinea-pigs: inhibition of IgE-but not of IgG-mediated anaphylaxis,” British Journal of Pharmacology, vol. 76, no. 1, pp. 139–147, 1982. View at Google Scholar
  6. D. Y. Leung, M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid, “New insights into atopic dermatitis,” The Journal of Clinical Investigation, vol. 113, no. 5, pp. 651–657, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. O'Garra, “Cytokines induce the development of functionally heterogeneous T helper cell subsets,” Immunity, vol. 8, no. 3, pp. 275–283, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Werfel, J.-P. Allam, T. Biedermann et al., “Cellular and molecular immunologic mechanisms in patients with atopic dermatitis,” The Journal of Allergy and Clinical Immunology, vol. 138, no. 2, pp. 336–349, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. S. K. Kritas, A. Saggini, G. Varvara et al., “Impact of mast cells on the skin,” International Journal of Immunopathology and Pharmacology, vol. 26, no. 4, pp. 855–859, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. U. Trefzer, M. Hofmann, W. Sterry, and K. Asadullah, “Cytokine and anticytokine therapy in dermatology,” Expert Opinion on Biological Therapy, vol. 3, no. 5, pp. 733–743, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. X.-P. Chen, W. Li, X.-F. Xiao, L.-L. Zhang, and C.-X. Liu, “Phytochemical and pharmacological studies on Radix Angelica sinensis,” Chinese Journal of Natural Medicines, vol. 11, no. 6, pp. 577–587, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Lü, J. Zhang, L. Li, C. Jiang, and C. Xing, “Cancer Chemoprevention with Korean Angelica: Active Compounds, Pharmacokinetics, and Human Translational Considerations,” Current Pharmacology Reports, vol. 1, no. 6, pp. 373–381, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Lee, Y. Sohn, M.-J. Lee et al., “Effects of Angelica acutiloba on mast cell-mediated allergic reactions in vitro and in vivo,” Immunopharmacology and Immunotoxicology, vol. 34, no. 4, pp. 571–577, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Y. Jeong, H. M. Kim, K. H. Lee et al., “Quantitative analysis of marker compounds in Angelica gigas, Angelica sinensis, and Angelica acutiloba by HPLC/DAD,” Chemical & Pharmaceutical Bulletin, vol. 63, no. 7, pp. 504–511, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. U. J. Bae, E. K. Choi, M. R. Oh, S. J. Jung, J. Park, T. S. Jung et al., “Angelica gigas Ameliorates Hyperglycemia and Hepatic Steatosis in C57BL/KsJ-db/db Mice via Activation of AMP-Activated Protein Kinase Signaling Pathway,” American Journal of Chinese Medicine, vol. 44, no. 8, pp. 1627–1638, 2016. View at Google Scholar
  16. W. J. Bae, U. S. Ha, J. B. Choi, K. S. Kim, S. J. Kim, H. J. Cho et al., “Protective effect of decursin extracted from angelica gigas in male infertility via nrf2/ho-1 signaling pathway,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 5901098, 9 pages, 2016. View at Publisher · View at Google Scholar
  17. T. W. Oh, K. H. Park, H. W. Jung, and Y. K. Park, “Neuroprotective effect of the hairy root extract of Angelica gigas NAKAI on transient focal cerebral ischemia in rats through the regulation of angiogenesis,” BMC Complementary and Alternative Medicine, vol. 15, p. 101, 2015. View at Google Scholar
  18. J. W. Yun, J. H. Che, E. Kwon, Y. S. Kim, S. H. Kim, J. R. You et al., “Safety evaluation of Angelica gigas: Genotoxicity and 13-weeks oral subchronic toxicity in rats,” Regulatory Toxicology and Pharmacology, vol. 72, no. 3, pp. 473–480, 2015. View at Google Scholar
  19. K. M. Kim, Y. J. Lee, Y. G. Hong, and J. S. Kang, “Oral acute and subacute toxicity studies of decursin and decursinol angelate of Angelica gigas Nakai,” Mol Cell Toxicol, vol. 5, no. 2, pp. 153–159, 2009. View at Google Scholar
  20. S. R. Oh, S. Ok, T. S. Jung et al., “Protective effect of decursin and decursinol angelate-rich Angelica gigas Nakai extract on dextran sulfate sodium-induced murine ulcerative colitis,” Asian Pacific Journal of Tropical Medicine, vol. 10, no. 9, pp. 864–870, 2017. View at Publisher · View at Google Scholar
  21. C. M. Klingerman, M. E. Stipanovic, M. Bader, and C. J. Lynch, “Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL/6J mice,” Schizophrenia Bulletin, vol. 40, no. 2, pp. 327–340, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. J. Kim, S. W. Jin, G.-H. Lee, Y. A. Kim, and H. G. Jeong, “Evaluation of estrogenic activity of extract from the herbal mixture cynanchum wilfordii hemsley, phlomis umbrosa turczaninow, and angelica gigas nakai,” Toxicological Research, vol. 33, no. 1, pp. 71–77, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. H. J. Kim, H. M. Kim, B. Ryu et al., “Constituents of PG201 (Layla®), a multi-component phytopharmaceutical, with inhibitory activity on LPS-induced nitric oxide and prostaglandin E2 productions in macrophages,” Archives of Pharmacal Research, vol. 39, no. 2, pp. 231–239, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-H. Lee, J. H. Lee, E.-J. Kim et al., “A novel derivative of decursin, CSL-32, blocks migration and production of inflammatory mediators and modulates PI3K and NF-κB activities in HT1080 cells,” Cell Biology International, vol. 36, no. 7, pp. 683–688, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-J. Park, H.-S. Cha, Y.-H. Lee et al., “Effect of nodakenin on atopic dermatitis-like skin lesions,” Bioscience, Biotechnology, and Biochemistry, vol. 78, no. 9, pp. 1568–1571, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. B.-K. Park, Y.-C. Park, I. C. Jung et al., “Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC/Nga murine model of atopic dermatitis,” Journal of Ethnopharmacology, vol. 165, pp. 54–60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. I. S. Kim, D.-H. Kim, C.-Y. Yun, and J.-S. Lee, “A (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]-chromen-3-yl-ester, attenuates the development of atopic dermatitis-like lesions in NC/Nga mice,” Molecular Biology Reports, vol. 40, no. 3, pp. 2541–2548, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Sugimoto, K. Umakoshi, N. Nojiri, and C. Kamei, “Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice,” European Journal of Pharmacology, vol. 351, no. 1, pp. 1–5, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Lee, N. Y. Lee, K.-S. Chung, S.-Y. Cheon, K.-T. Lee, and H.-J. An, “Roxatidine attenuates mast cell-mediated allergic inflammation via inhibition of NF-κ B and p38 MAPK activation,” Scientific Reports, vol. 7, Article ID 41721, 2017. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Jiang, T. Tsumuro, M. Takubo, Y. Fujii, and C. Kamei, “Antipruritic and antierythema effects of ascomycete Bulgaria inquinans extract in ICR mice,” Biological & Pharmaceutical Bulletin, vol. 28, no. 12, pp. 2197–2200, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. H.-J. Yoon, M.-S. Jang, H.-W. Kim et al., “Protective effect of diet supplemented with rice prolamin extract against DNCB-induced atopic dermatitis in BALB/c mice,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. C.-F. Wahlgren, “Itch and atopic dermatitis: an overview,” The Journal of Dermatology, vol. 26, no. 11, pp. 770–779, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Gutgesell, S. Heise, A. Seubert, D. O. Stichtenoth, J. C. Frölich, and C. Neumann, “Comparison of different activity parameters in atopic dermatitis: Correlation with clinical scores,” British Journal of Dermatology, vol. 147, no. 5, pp. 914–919, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Noh and K. Lee, “Blood eosinophils and serum IgE as predictors for prognosis of interferongamma therapy in atopic dermatitis,” Allergy, vol. 53, no. 12, pp. 1202–1207, 1998. View at Publisher · View at Google Scholar
  35. H. Sugiura, M. Uehara, and T. Maeda, “IgE-positive epidermal Langerhans cells in allergic contact dermatitis lesions provoked in patients with atopic dermatitis,” Archives of Dermatological Research, vol. 282, no. 5, pp. 295–299, 1990. View at Publisher · View at Google Scholar · View at Scopus
  36. S. C. Bischoff, G. Sellge, M. P. Manns, and A. Lorentz, “Interleukin-4 induces a switch of human intestinal mast cells from proinflammatory cells to Th2-type cells,” International Archives of Allergy and Immunology, vol. 124, no. 1-3, pp. 151–154, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Ochi, N. H. De Jesus, F. H. Hsieh, K. F. Austen, and J. A. Boyce, “IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 97, no. 19, pp. 10509–10513, 2000. View at Google Scholar
  38. K. Jujo, H. Renz, J. Abe, E. W. Gelfand, and D. Y. M. Leung, “Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis,” The Journal of Allergy and Clinical Immunology, vol. 90, no. 3, pp. 323–332, 1992. View at Publisher · View at Google Scholar · View at Scopus
  39. J. B. Eggesbø, I. Hjermann, P. K. Lund, G. B. Joø, R. Øvstebø, and P. Kierulf, “LPS-induced release of IL-1β, IL-6, IL-8, TNF-α and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein,” Cytokine, vol. 6, no. 5, pp. 521–529, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Y. Choi, M. H. Kim, J. Y. Lee, J. Hong, S.-H. Kim, and W. M. Yang, “Topical application of Kochia scoparia inhibits the development of contact dermatitis in mice,” Journal of Ethnopharmacology, vol. 154, no. 2, pp. 380–385, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Wang, J. Yuan, H.-X. Wu et al., “Total glucosides of paeony inhibit the inflammatory responses of mice with allergic contact dermatitis by restoring the balanced secretion of pro-/anti-inflammatory cytokines,” International Immunopharmacology, vol. 24, no. 2, pp. 325–334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. J.-J. Kim, H. W. Cho, H.-R. Park, U. Jung, S.-K. Jo, and S.-T. Yee, “Preventative Effect of an Herbal Preparation (HemoHIM) on Development of Airway Inflammation in Mice via Modulation of Th1/2 Cells Differentiation,” PLoS ONE, vol. 8, no. 7, Article ID e68552, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. L. E. Fredenburgh, J. Ma, and M. A. Perrella, “Cyclooxygenase-2 Inhibition and Hypoxia-Induced Pulmonary Hypertension: Effects on Pulmonary Vascular Remodeling and Contractility,” Trends in Cardiovascular Medicine, vol. 19, no. 2, pp. 31–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Steinhoff, U. Neisius, A. Ikoma et al., “Proteinase-activated receptor-2 mediates itch: A novel pathway for pruritus in human skin,” The Journal of Neuroscience, vol. 23, no. 15, pp. 6176–6180, 2003. View at Google Scholar · View at Scopus
  45. J. H. Chung, S. Kang, J. Varani, J. Lin, G. J. Fisher, and J. J. Voorhees, “Decreased extracellular-signal-regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo,” Journal of Investigative Dermatology, vol. 115, no. 2, pp. 177–182, 2000. View at Publisher · View at Google Scholar · View at Scopus